NuScale Power stock falls after UBS downgrade to sell
Source: Investing.com

NuScale Power shares fell 4.4% premarket after UBS downgraded the small modular reactor developer to Sell and cut its price target to $6 from $10, implying roughly 40% downside. UBS cited a five-plus-year construction timeline, lack of firm customer commitments, and an estimated $700 million of cumulative cash burn during 2026-28. The firm expects only one project to start construction in 2028 and forecasts losses through 2030, with its $29 million 2028 EBITDA estimate far below the market-implied $124 million.
Analysis
SMR is a duration-sensitive equity masquerading as an energy-transition exposure: most of its valuation depends on terminal project economics rather than near-term operating cash flow. A higher-for-longer rate environment raises both the discount rate applied to distant cash flows and prospective project-financing costs, creating a double hit that is not captured by a simple comparison of target prices. The key near-term risk is not merely another analyst downgrade; it is that any evidence of slower customer conversion forces investors to revalue SMR against cash runway rather than modeled 2030 revenue.
The second-order beneficiary is BWXT, which has nuclear-services and component exposure with existing revenue streams rather than a binary development timeline. More broadly, capital may rotate from pre-revenue advanced-reactor developers such as SMR, OKLO and NNE into uranium and established nuclear-infrastructure names if investors conclude that incremental power demand will be served first by life extensions, uprates and conventional new-build supply chains. That said, a broad selloff in speculative nuclear equities could initially pressure all three developer names regardless of their individual milestones.
Over the next 1-3 months, procurement updates, binding offtake commitments, customer deposits, and evidence of externally financed project development are the relevant catalysts; nonbinding announcements should have diminishing valuation impact. Over 6-18 months, the decisive question is whether SMR can fund development without substantial equity issuance. The bearish thesis is falsified by a credible, financed construction commitment with a creditworthy counterparty, or by cash-burn guidance materially below expectations; absent those, downside asymmetry remains unfavorable because the equity must repeatedly finance a long-dated asset base.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly negative
Sentiment Score
-0.62
Ticker Sentiment
Key Decisions for Investors
- Initiate or maintain a tactical short SMR on rallies toward the prior $10-area valuation anchor; target $6 over 3-6 months, with a risk stop on a binding, fully financed customer construction award or sustained trading above $12.
- Express relative value via long BWXT / short SMR over 6-12 months in equal dollar amounts. The trade isolates the shift from speculative reactor-development optionality toward monetizable nuclear supply-chain exposure; reassess if SMR secures contracted project financing before BWXT's next earnings cycle.
- Avoid shorting the entire advanced-nuclear basket indiscriminately. Use SMR as the idiosyncratic short and keep OKLO/NNE on watch for sympathy weakness, since a sector-wide risk-on move driven by data-center power-demand headlines can temporarily overwhelm fundamental dispersion.
- Set an event-driven alert for cash runway, quarterly operating cash burn, RoPower milestones, and TVA/customer updates. A capital raise at a meaningful discount, reduced project scope, or further slippage would likely accelerate the equity de-rating; a customer deposit or non-recourse financing package would invalidate the near-term short thesis.
More News
- UBS reiterates Buy on Darden stock ahead of earnings report
- BNP Paribas Exane cuts Restoration Hardware stock price target on margin risks
- UBS reiterates Birkenstock stock Buy rating on market share outlook
- Stifel reiterates Salesforce stock Buy rating on revenue growth
- TD Cowen raises Oneok stock price target to $93 on M&A outlook
- Oppenheimer reiterates Perform rating on SolarEdge stock